![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
New Pain Treatment Triumphs Morphine (OTC:NPHC)
Michael Vlaicu (September 11th, 2009) Writes:
Nutra Pharma Corp.
(Public, OTC:NPHC)
Step aside Morphine, the new king of chronic pain treatment has entered the building. With Nutra Pharma’s stock rising nearly 2300% year-to-date, its time we see what all the commotion is about. StocksHaven Investments takes a closer look at Nutra Pharma Corp., which believes will begin generating significant revenues within the next 12 months. The company has recently made waves throughout the biotech space with their recent “Best New Product” award winning drug, Cobroxin. The product is the first clinically proven treatment for stage 2 (moderate to severe) chronic pain, and was awarded the honour at the Efficient Collaborative Retail Marketing (ECRM) Conference in Miami, Florida. Winning this was no easy task, as a handful of well known companies attended the conference. The
...Adrenoleukodystrophy, Adrenomyeloneuropathy;, AMN, amyotrophic lateral sclerosis, anticholinergic therapeutic protein products, Arthritis, autoimmune disorders, biologic product, Biopharmaceutical, Biopharmaceuticals, Biotech Company, Biotechnology, Blue channel, cancer, cent;, ceo, covering, covering technologies, cramps, Decision Resources Inc., designer, Designer Diagnostics Inc., drug addiction;, drug delivery, drug development, Drug Discovery, drug discovery subsidiary;, Fda, Florida, hepatitis, HIV, HIV technologies, Infectious Diseases, joint pain, lower back pain, Miami, Michael Vlaicu;, migraines;, Mississippi, Multiple Sclerosis, Myasthenia gravis, Nanologix Inc., neck aches, neuralgia, neurological disorder, neurological disorders, Nutra Pharma Corp.;, Nutra Pharma Inc., Orange channel, pain, Pharmaceutical, Pharmaceutical Products, prized product, ReceptoPharm Inc., Rheumatoid Arthritis, Rik J Deitsch;, RPI-MN, severe chronic, shared aerosol delivery technology, Should Nutra Pharma Corp., shoulder pain, stage biopharmaceutical;, Stocks to Watch, suggested retail price, TB, tuberculosis;, United States, USD, viral diseases;, Webinar, World Health Organization
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.